FOLH1 and prostate cancer: An early experience with [68Ga]Ga-DOTAZOL imaging in humans was reported by Zhang et al. [190], particularly in prostate cancer patients for whom DOTAZOL showed an approximately threefold higher uptake in skeletal lesions than [68Ga]Ga-PSMA-11.